This study examined the contribution made by organic cation transporters (hOCT/rOct) to the saturable component of the renal uptake of 1-methyl-4phenylpyridinium, tetraethylammonium (TEA), cimetidine and metformin into rOct2-expressing HEK293 cells and rat kidney slices. All the test compounds accumulated in the rat kidney slices in a carrier-mediated manner. The Michaelis-Menten constant (K m ) values for saturable uptake of TEA, cimetidine and metformin into rat kidney slices were relatively comparable with those for the rOct2expressing HEK293 cells. In addition, the relative uptake activity values of TEA, cimetidine and metformin in rat kidney slices were similar to those in rOct2expressing HEK293 cells. This suggests that the saturable components involved in the renal uptake of TEA, cimetidine and metformin are mediated mainly by rOct2. The saturable uptake profile of cationic compounds into rat kidney can be evaluated in both cDNA-expressing cells and rat kidney slices, as well as the transporter expression pattern. This approach can also be used to estimate the saturable uptake mechanism of cationic compounds into the human kidney when human kidney slices and hOCT2expressing cells are used.
Introduction
The kidney plays an important role in the urinary excretion of endogenous wastes and xenobiotics, including drugs and their metabolites, via glomerular filtration and tubular secretion. It also maintains ion and water homeostasis. 1, 2 To accomplish this, the kidney's tubular epithelial cells possess multiple plasma membrane transporters that use adenosine triphosphate (ATP) and transmembrane ion gradients to drive active secretion. In addition, the carrier-mediated transport of xenobiotics and their metabolites is confined predominantly to the proximal tubule, and separate carrier systems exist for the active uptake and secretion of organic cations and anions in the liver and kidney. For the uptake of several types of drugs and other xenobiotics, such as pravastatin and 4-methyl-K-I Umehara, T Iwatsubo, K Noguchi et al.
Rat renal organic cation transporter 2 umbelliferone, the hepatic uptake process is the rate-limiting step for systemic clearance. 3, 4 Therefore, the uptake process can also be an important determinant of the renal clearance of drugs. Thus, the in vitro assessment of the uptake of compounds across the basolateral membrane is important for assessing renal clearance. Organic cations are transported from the blood to the intracellular compartment mainly by the three electrogenic organic cation transporter subtypes of hOCT1/rOct1, hOCT2/rOct2, and hOCT3/rOct3. These transporters contribute to the tissue-selective distribution of cationic compounds, including endogenous substrates, drugs and their metabolites. 5 In humans, hOCT2 (known as SLC22A2) is expressed predominantly by the basolateral membrane of the renal proximal tubular cells and mediates uptake from the blood into the kidney during the renal excretion of organic cations. 6 In rats, rOct1 expression is at its highest in the kidney, with detectable expression in the liver and intestine. 7 Similarly, rOct2 is highly expressed in the kidney, with no detectable transcripts in other organs. 8, 9 In our previous report, we demonstrated that 1-methyl-4-phenylpyridinium (MPP), tetraethylammonium (TEA), and cimetidine were substrates for rOct1, rOct2 and hOCT2 using cDNAexpressing HEK293 cells. 10 Furthermore, recent analyses using transiently expressing cells showed that metformin is a rOct2 and hOCT2
substrate. 11 Considering the localization of rOct1 and rOct2 in rats (and hOCT2 in humans), the renal uptake of MPP, TEA, cimetidine and metformin may be handled by these transporters.
Even if a compound is a good substrate for rOct1, rOct2, or hOCT2, it is unclear whether these transporters play a major role in the transport of such compounds across the renal membrane. The purpose of the present study was to investigate the importance of rOct1 and/or rOct2 in the total renal uptake of cationic compounds in rats. MPP, TEA, cimetidine and metformin, which are known to be substrates of the organic cation transport system, were selected for use. In particular, metformin, one of the biguanide agents, is excreted extensively into the urine in mice, rats and humans. 12 -14 It is essential to evaluate the contribution of rOct1 and/or rOct2 to the total renal uptake of metformin in rats because the renal excretion of metformin in rats may be altered when there are changes in the expression level or function of these transporters caused by pathological conditions, single nucleotide polymorphisms, or transporter-mediated drug-drug interactions. Performing this study in rats is also very useful and applicable for speculating about the contribution of hOCT2 to the saturable renal uptake process and/or the renal clearance of organic cations in humans.
In the present study, in order to estimate the contribution of rOct1 and/or rOct2 to saturable uptake into rat kidney slices, the clearance of saturable uptake was also examined using rOct2-expressing HEK293 cells. The data on the saturable uptake of MPP, TEA, cimetidine and metformin via rOct1 and partly rOct2 were taken from our previous reports. 10, 15 Subsequently, the clearance of saturable uptake by the cDNA transfectants was compared with that by the kidney slices, and TEA, metformin and cimetidine were found to be transported mainly by rOct2, but not rOct1, using both cDNA transfected cells and rat kidney slices. This method, which examines the involvement of rOct1/rOct2 in the renal uptake of organic cations using MPP as a model ligand (previously reported as the relative activity factor [RAF] concept for the K-I Umehara, T Iwatsubo, K Noguchi et al.
Rat renal organic cation transporter 2 evaluation of the renal uptake of organic anions), 16 is speculated to be an important tool for investigating the renal uptake mechanism of not only organic anions, but also organic cations. 
Materials and methods

CHEMICALS AND REAGENTS
CONSTRUCTION OF STABLY-TRANSFECTED HEK293 CELLS EXPRESSING rOct2 AND CELL CULTURE
The HEK293 cells that were stably expressing rOct2 and negative control cells (mocktransfected HEK293 cells) were constructed as described previously. 10 Transporterexpressing or mock-transfected HEK293 cells were grown in DMEM supplemented with 10% fetal bovine serum, 1% penicillin-streptomycin and 100 µg/ml Zeocin™, and incubated at 37°C in an atmosphere of 5% carbon dioxide with 95% humidity. The cells were subcultured in a medium containing 0.05% trypsin-EDTA solution. Cells were then seeded in poly-Dlysine-coated 12-well plates at a density of 1.2 × 10 5 cells/well. For the transport study, the cell culture medium was replaced 24 h before the transport assay with culture medium supplemented with 5 mM sodium butylate to induce the expression of rOct2.
TRANSPORT STUDY USING rOct2-EXPRESSING HEK293 CELLS
The transport study was performed as described previously. 10 Uptake was initiated by adding Krebs-Henseleit buffer containing radiolabelled substrates after the cells had been washed twice and pre-incubated with Krebs-Henseleit buffer at 37°C for 15 min. The Krebs-Henseleit buffer consisted of 2.0 g/l D-glucose, 0.141 g/l magnesium sulphate (anhydrous), 0.16 g/l potassium phosphate monobasic, 0.35 g/l potassium chloride, 6.9 g/l sodium chloride (Sigma-Aldrich), 0.373 g/l calcium chloride dihydrate, 1.5 g/l HEPES and 2.1 g/l sodium bicarbonate. The pH was adjusted to 7.4 with sodium hydroxide. The uptake was terminated at the designated time by adding ice-cold Krebs-Henseleit buffer after the incubation buffer was removed. The cells were then washed twice with 1 ml of ice-cold Krebs-Henseleit buffer, solubilized in 0.5 ml of 1.0 mol/l sodium hydroxide, and kept at 4°C overnight. Aliquots (0.5 ml) were transferred to scintillation vials after adding 0.25 ml of 2.0 mol/l hydrochloric acid. The radioactivity associated with the cells and incubation buffer was measured in a liquid scintillation counter (Tricarb-2700TR; PerkinElmer Life 
PREPARATION OF RAT KIDNEY SLICES
Male Sprague-Dawley rats (7 -8 weeks old) were purchased from Charles River Laboratories (Yokohama, Kanagawa, Japan) and were used in all experiments. The rats were euthanized by ether inhalation, and the kidneys were removed promptly, decapsulated and placed in ice-cold oxygenated incubation buffer. The incubation buffer consisted of 120 mmol/l sodium chloride, 16.2 mmol/l potassium chloride, 1 mmol/l calcium chloride, 1.2 mmol/l magnesium sulphate, and 10 mmol/l monosodium/disodium phosphate adjusted to pH 7.5. Rat kidney cortical slices (approximately 1.0 mm in thickness) were cut freehand with trimming blades (Feather Safety Razor Co. Ltd, Osaka, Japan) in a rodent brain matrix apparatus (ASI Instruments Inc., Warren, MI, USA), using the matrix slide as a cutting guide. The first slice was discarded so that each subsequent slice had two cut surfaces. The slicing apparatus and kidney were kept wet at all times with oxygenated incubation buffer. The slices were blotted to remove excess rinse medium and randomly distributed into flasks, each of which contained oxygenated incubation buffer and had been preincubated for 5 min at 37°C. The experimental protocol was approved by the Animal Ethical Committee of Astellas Pharma Inc. (Tokyo, Japan).
TRANSPORT STUDY USING RAT KIDNEY SLICES
After pre-incubation, one rat kidney slice was randomly selected to be incubated in a 12-well plate with 3 ml of oxygenated incubation buffer containing radiolabelled substrates in each well. After being incubated at 37°C for an appropriate time, each slice was rapidly removed from the incubation buffer, washed twice in ice-cold saline, blotted on filter paper, weighed and allowed to dissolve in 1 ml of soluene-350 (PerkinElmer Life Sciences Products, Inc.) at 50°C overnight. The solubilized tissue samples were then mixed with 10 ml of scintillation cocktail (Hionic Fluor). After these solubilized samples were incubated overnight at room temperature, the radioactivity in each tissue sample was measured in a liquid scintillation counter (Tricarb-2700TR).
KINETIC ANALYSIS
Transport study using rOct2-expressing HEK293 cells
The metformin uptake into rOct2-expressing HEK293 cells and mock-transfected HEK293 cells was expressed as the uptake volume (µl/mg protein). This was calculated as the amount of radioactivity associated with the cells divided by its concentration in the incubation medium. First, the timedependent uptake of [ 14 C]-metformin (10 µM) for rOct2 was determined at 0.25, 0.5, 1, 2, 3, 5, 10 and 15 min after the initiation of incubation. Then the uptake time period, during which the linearity of transport activity was maintained, was determined. Subsequently, the concentration-dependence of the uptake clearance of [ 14 C]-metformin was evaluated for rOct2 at the designated time (5 min) within the aforementioned time period. The uptake clearance of [ 14 C]metformin was calculated by dividing the K-I Umehara, T Iwatsubo, K Noguchi et al.
Rat renal organic cation transporter 2 uptake volume (µl/mg protein) by the incubation time (5 min) . Similarly, the concentration-dependent uptake of [ 3 H]cimetidine via rOct2 under linear uptake conditions was examined by referring to the time-dependent uptake of [ 3 H]-cimetidine via rOct2 examined previously. 10 Kinetic parameters were estimated using Michaelis-Menten plots based on the following equation
where v/S is the initial uptake clearance of the substrate (µl/min per mg protein), S is the substrate concentration in the medium (µM), K m is the Michaelis-Menten constant (µM), V max is the maximum uptake rate (nmol/min per mg protein) and P dif represents the non-saturable uptake clearance (µl/min per mg protein). Fitting was performed by the non-linear leastsquares method using WinNonlin ® (Pharsight Corporation, Mountain View, CA, USA). The concentration range of the ligands was 10 -10 000 µM for metformin and 1 -1000 µM for cimetidine. The same type of data on the saturable uptake of cationic compounds via rOct1 and partly rOct2 from previous reports was also used in this study. 10, 15 Transport study using rat kidney slices The uptake of 
where v/S is the uptake clearance of the substrate (ml/min per g kidney), S is the substrate concentration in the medium (µM), K m is the Michaelis-Menten constant (µM), V max is the maximum uptake rate (nmol/min per g kidney) and P dif represents the nonsaturable uptake clearance (ml/min per g kidney). In addition, the concentrationdependency of the relative contribution (%) of the saturable component (expressed as V max /(K m +S) in equation 2) and the nonsaturable component (expressed as P dif in equation 2) to the uptake clearance (v/S in equation 2) of [ 3 H]-MPP and [ 14 C]-metformin in rat kidney slices was simulated using the K m , V max and P dif values of these two compounds obtained from the kinetic analyses described above. The simulation was performed using Microsoft Excel.
COMPARISON OF THE RELATIVE UPTAKE ACTIVITY OF CATIONIC COMPOUNDS BETWEEN KIDNEY SLICES AND cDNA TRANSFECTANTS
To investigate the transporter-mediated Rat renal organic cation transporter 2 renal uptake mechanism of the cationic compounds, the relative uptake activity of the cationic compounds (TEA, cimetidine, and metformin) into rat kidney slices and cDNA transfectants (R rat kidney and R rOct2 ) was evaluated using the saturable component of the intrinsic uptake clearance of MPP as the reference value. MPP was selected as a reference compound for this analysis because it was a relatively high contributor to the saturable portion of the total renal uptake clearance (see Results). The relative uptake activity of organic cations in rats was calculated using the following equations: Figure 1 shows the time-dependent uptake of [ 14 C]-metformin (10 µM) by mocktransfected and rOct2-expressing HEK293 cells. The uptake of [ 14 C]-metformin was greater in rOct2-expressing HEK293 than mock-transfected HEK293 cells, and the uptake values at 15 min (the uptake value in the steady-state) were 12.7-fold higher for rOct2-expressing than mock-transfected cells.
Results
UPTAKE OF [ 3 H]-CIMETIDINE AND [ 14 C]-METFORMIN BY rOct2-EXPRESSING HEK293 CELLS
For analysis of the concentrationdependent uptake of [ 14 C]-metformin via rOct2, the initial uptake rates of various of metformin were determined at the earliest time that was practically and technically possible. The uptake time for [ 14 C]-metformin was 5 min for the rOct2-expressing HEK293 cells (Fig.  1) . The concentration-dependent uptake of [ 14 C]-metformin in rOct2-expressing HEK293 cells could be explained by the presence of two components, one saturable and one non-saturable, rather than just one, as in the one-site model (Fig. 2) . Similarly, the concentration-dependent uptake of [ 3 H]cimetidine via rOct2 under linear uptake conditions (during 1 min) was examined by referring to a previously determined timedependent uptake of [ 3 H]-cimetidine via rOct2. 10 The K m , V max , V max /K m and P dif values obtained via rOct2-mediated uptake were 1020 µM, 18.2 nmol/min per mg protein, 17.8 and 1.5 µl/min per mg protein for metformin, and 230 µM, 3.4 nmol/min per mg protein, 14.7 and 2.8 µl/min per mg protein for cimetidine, respectively ( Table 1 ).
UPTAKE OF [ 3 H]-MPP, [ 14 C]-TEA, [ 3 H]-CIMETIDINE AND [ 14 C]-METFORMIN BY RAT KIDNEY SLICES
The time-dependent uptake of [ 3 H]-MPP (0.6 nM), [ 14 C]-TEA (5.0 µM), [ 3 H]-cimetidine (12 nM), and [ 14 C]-metformin (10 µM) into rat kidney slices was examined at 1, 5, 10, 30 and 60 min. The time profiles of the uptake of these compounds in rat kidney slices at 37°C are shown in Fig. 3 .
The saturable uptake of [ 3 H]-MPP, [ 14 C]-TEA, [ 3 H]-cimetidine and [ 14 C]-metformin into rat kidney slices is shown in Fig. 4 , and all the kinetic parameters are summarized in Table 1 . The uptake time in the concentration-dependent uptake study was 10 min for Data from our previous study. 15 The K m , V max and P dif values were determined using non-linear regression analysis, as described in Materials and Methods. Data used for the analyses were taken mainly from Figs 2 and 4. MPP, 1-methyl-4-phenylpyridinium; TEA, tetraethylammonium; NE, not examined.
K-I Umehara, T Iwatsubo, K Noguchi et al. Rat renal organic cation transporter 2
the test compounds into rat kidney slices can be attributed to two components, one saturable and one non-saturable, rather than just one, as in the one-site model. The saturable uptake clearance in rat kidney slices was in the order of MPP (82.3) > TEA (39.0) > metformin (19.9) > cimetidine (4.62) (all values as ml/min per g kidney).
In addition, the relative contribution of the saturable and non-saturable components to the renal uptake clearance of MPP and metformin in rats was simulated using the K m , V max , and P dif values of these two compounds obtained from the kinetic analyses (Fig. 5 ). In the linear condition, for the concentration-dependent uptake of MPP and metformin into rat kidney slices, the ratio of the saturable to non-saturable components for total renal uptake clearance was 3:2 for both compounds. The relative contribution of the saturable component to the total renal uptake clearance in rat kidney slices decreased in a concentrationdependent manner for MPP and metformin.
COMPARISON OF THE RELATIVE UPTAKE ACTIVITY OF CATIONIC COMPOUNDS BETWEEN KIDNEY SLICES AND cDNA TRANSFECTANTS
To investigate the contribution of rOct2mediated uptake to the renal uptake of TEA, cimetidine and metformin, the relative uptake activity (R rat kidney and R rOct2 ) of these compounds into rat kidney slices and cDNA transfectants was evaluated using the saturable component of the intrinsic uptake clearance of MPP as the reference value. The saturable intrinsic clearance for the rOct2mediated uptake of MPP, TEA, cimetidine and metformin are summarized in Table 1 . Table 2 presents a summary of the relative uptake activities of TEA, cimetidine and metformin in cDNA transfectants and kidney slices. The R rat kidney /R rOct2 values were 1.09, 0.34 and 1.21 for TEA, cimetidine and metformin, respectively.
Discussion
In the present study, the contribution of rOct2 (and partly rOct1) to the saturable component of the renal uptake of cationic compounds in rats was investigated. The uptake into rOct1-and rOct2-expressing HEK293 cells and rat kidney slices was determined in terms of their affinity and transport activity, whereas the data on the uptake of cationic compounds via rOct1 and (partly) rOct2 were taken from our previous results. 10, 15 Uptake studies using rat kidney slices are well known as important tools for evaluating the uptake process of compounds via the basal membrane of tubular cells. 17 In the present study, various kinetic parameters (K m , V max , V max /K m and P dif ) for the saturable uptake of cationic compounds into rOct1/rOct2-expressing HEK293 cells and rat kidney slices, which were obtained from previous and present studies, were compared. Table 1 shows which parameters are from our previous and/or present studies. First, the uptake of metformin via rOct2 was demonstrated using transfected HEK293 cells (Figs 1 and 2) . Significant time-dependent uptake of metformin was observed in rOct2-expressing HEK293 cells ( Fig. 1 ) and the K m value of metformin for rOct2 was 1020 µM, which was comparable with the reported K m value (630 µM) in transiently rOct2-expressing HEK293 cells. 11 A concentration-dependent uptake study of cimetidine that used the same rOct2 expression system showed a K m value (230 µM) comparable with that previously reported (68.8 µM). 18 It should also be noted that the K m values of metformin and The R rOct2 and R rat kidney values were estimated as described in Materials and Methods and the ratio of the relative uptake activities of cDNA transfectants into kidney slices (R rat kidney /R rOct2 ) was calculated. Data used for the analyses were taken mainly from Fig. 2, Fig. 4 , Table 1 and our previously reported values. 10 TEA, tetraethylammonium. Data for the simulation (K m , V max and P dif ) of MPP and metformin uptake into rat kidney slices were taken mainly from Fig. 4 and Table 1 , and equation (2) Metformin concentration (µM) Rat renal organic cation transporter 2 cimetidine for rOct2-mediated uptake were also comparable with previously reported values (990 µM and 99 µM, respectively) for hOCT2. 11, 19 It was speculated, therefore, that there was no species difference in the affinity for the hOCT2/rOct2-mediated renal uptake of metformin and cimetidine between humans and rats. Secondly, the saturable renal uptake of several cationic compounds (MPP, TEA, cimetidine and metformin) in rats was investigated using rat kidney slices. MPP, TEA, cimetidine and metformin were taken up into rat kidney slices in a time-dependent and saturable manner (Figs 3 and 4) . The parameters obtained are summarized in Table 1 . The profiles of concentrationdependent uptake into rat kidney slices for all the test compounds can be attributed to one saturable carrier-mediated component and one non-saturable one, whereas these compounds are substrates for both rOct1 and rOct2, 10, 15 and the expression of these two transporters has been reported on the basal side of the tubular cells in the rat kidney. 6, 8, 9 The K m values reported for rOct1 and rOct2 were 21.1 and 43.7 µM, respectively, for MPP and 57.8 and 213 µM, respectively, for TEA (Table 1) . 10 The K m value obtained for MPP uptake into rat kidney slices (29.9 µM) was comparable with that via both rOct1 and rOct2 whereas the obtained K m value of TEA uptake into rat kidney slices (222 µM) was closer to that via rOct2, rather than rOct1. Similarly, the K m value for metformin uptake into rat kidney slices (1350 µM) was much closer to the K m value via rOct2 (1020 µM) than that via rOct1 (280 µM) ( Table 1 ). This means that the rOct1-mediated uptake of metformin into rat kidney slices was not reflected, although the transport affinity (K m value) of metformin for rOct1 was higher (smaller) than that for rOct2. This suggests that the expression level of rOct2 may be greater than that of rOct1 on the basal side of tubular cells in the rat kidney. In addition, the K m value for cimetidine uptake into kidney slices (90.2 µM) was also comparable with that via rOct2 (230 µM) obtained in this study ( Table 1 ). Comparison of these K m values suggests that TEA, cimetidine and metformin are taken up into the kidney mainly via rOct2. MPP may be taken up via rOct1 and/or rOct2, considering that these two transporters are expressed in the basolateral membrane of the tubular cells in the kidney. Although rOct3 is also a major organic cation transporter in rats, like rOct1 and rOct2, previous reports state that TEA, cimetidine and metformin are not taken up into rOct3expressing cells. 10, 15 In contrast, the K m values for MPP uptake are similar among rOct1-, rOct2-and rOct3-expressing cells (21.1, 43.7 and 15.5 µM, respectively). 10 The K m value for the saturable uptake of MPP in rat kidney slices was comparable with those in rOct1-, rOct2-and rOct3-expressing cells ( Table 1) , but very weak expression of rOct3 in the rat kidney was reported. 20 Thirdly, it was also reported that cimetidine may be actively taken up into rat kidney via rat organic anion transporter 3 (rOat3), which is also expressed on the basolateral membrane of rat proximal tubules. 21, 22 However, treatment with probenecid, which inhibits organic anion transporters such as rOat3, did not affect the plasma concentration of cimetidine in rats, although the unbound plasma concentration was sufficient to inhibit rOat3mediated cimetidine uptake. 16 This indicates that rOct2, not rOat3, plays a major role in the renal uptake of cimetidine.
Finally, in addition to the comparison of K m values, the contribution of rOct2 to the saturable component of the renal uptake of cationic compounds in rats was evaluated Rat renal organic cation transporter 2 in terms of relative uptake activity. The clearance of the saturable component in the intrinsic uptake of TEA, cimetidine and metformin in rat kidney slices (normalized for the MPP values) was compared with those values obtained from the uptake into rOct2-expressing HEK293 cells. MPP was selected as the reference compound in this analysis because the saturable component of its uptake (V max /K m values) into rOct2expressing HEK293 cells, 10 as well as rat kidney slices, was relatively higher than the non-saturable component (P dif values) (Fig.  5 ). The expression level of rOct2 in the stably-expressing cDNA transfectant remained constant throughout this study. Therefore, this analysis, which uses relative uptake activity, is very meaningful in the evaluation of the contribution of rOct2 to the saturable component of the renal uptake process for cationic compounds. In fact, the degree to which rOat1 and rOat3 contribute to the saturable renal uptake of organic anions in rats was investigated previously by Hasegawa et al. 16 using this kind of method with cDNA transfected cells and rat kidney slices. In that study, the contribution of rOat1 and rOat3 to the renal uptake of organic anions and nucleotide derivatives was examined in rOat1-and rOat3-expressing cells and kidney slices using the RAF concept with paminohippuric acid and pravastatin as reference compounds for rOat1 and rOat3, respectively. 16 Hasegawa et al. 16 concluded that, for almost all of the anionic compounds tested, the relative uptake into rOat1-/rOat3-expressing cells corresponded almost 1:1 with that into rat kidney slices. As shown in Table 2 , the relative uptake activity of TEA, cimetidine and metformin into rat kidney slices was within three-times the difference in activity between kidney slices and rOct2-expressing cells. In this study, comparison of the K m values and relative uptake activities confirmed that the saturable components of the renal uptake of MPP in rats were mediated by rOct1 and/or rOct2, but those of TEA, cimetidine, and metformin were mediated mainly by rOct2.
In conclusion, the saturable uptake of cationic compounds into rat kidney slices examined in this study was very similar to that into rOct2-expressing HEK293 cells. This study suggests that the saturable renal uptake of cationic compounds via rOct2 (partly rOct1) can be estimated from that via cDNA transfectants. In addition, the ratio of the saturable and non-saturable components to the total renal uptake of cationic drugs can be evaluated in uptake studies using rat kidney slices, and the method using the relative uptake activity can be applicable to evaluating not only the renal uptake of anionic compounds, but also that of cationic compounds in rats by comparing them with previous findings on the renal uptake of organic anions. We concluded, therefore, that the combination of rOct1-and/or rOct2-expressing systems and rat kidney slices are necessary for evaluating the renal uptake process of cationic compounds. The present results help to clarify the contribution of rOct1and/or rOct2-mediated transport to the renal uptake process in rats and, in some cases, to the pharmacokinetic profile of drug candidates. The approach used in this study can also be applied to the estimation of the saturable uptake mechanism of cationic compounds into the human kidney using human kidney slices and hOct2-expressing cells.
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